Cancer Biology Research federal funding in FY2025

What the 93.396 × FY2025 join is

CFDA 93.396 and fiscal year 2025 meet here. $908,016,796.56 is the obligation sum on awards that carry both tags. A cancer-biology award coded to another year is out. A FY2025 award under a different cancer CFDA — including treatment research — is out even if the lab sounds related. This packet does not name institutes, campuses, or investigators. Unique recipients are unpublished.

Program-wide 3,004 awards totaling $6,672,662,526.62 remain the parent. Open CFDA 93.396, FY2025 federal spending, All programs, and All spending ties for the program book, the year hub, sibling codes, and other pairs. Do not add those pages into $908,016,796.56.

548 actions inside a $6.67 billion extract

Dividing $908,016,796.56 by 548 yields about $1,656,965.00. Research portfolios mix new awards, renewals, and supplements; 548 is not 548 unique labs. Means are not medians. Do not invent contractor or campus names.

FY2025’s share of $6,672,662,526.62 is a descriptive ratio of packet facts, not a finding that biology research slowed. Correlation is not causation. Other years are not this page. Treatment research (a different CFDA) is a different join.

Not a mechanism census or a survival score

$908,016,796.56 does not measure papers, mechanisms discovered, or survival rates. Those series are unpublished here. The cell sums obligations with CFDA 93.396 and a FY2025 tag. Medical advice is outside this page. Catalog title text is the heading, not an efficacy claim. This page does not split the total by cancer type.

Obligations, not outlays

Even a mid-count research file records commitments, not necessarily payments. $908,016,796.56 can include multi-year project periods that pay later. Citing it as cash already spent on cancer biology over-reads the field. No outlay total is in this packet.

Keep both keys. Dropping the year turns the figure into the program book; dropping the CFDA turns it into a year hub that includes unrelated science.

Citing Cancer Biology Research in FY2025

Cite USAspending.gov: Cancer Biology Research (CFDA 93.396), fiscal year 2025, $908,016,796.56 in obligations, and 548 awards. Name both sides. Keep “obligations.” The compact $908 million is the same cell rounded. Prefer CFDA 93.396 if the program table refreshed.

FY2025 federal spending still includes every other CFDA tagged to that year. All programs lists sibling codes. All spending ties indexes other pairs. A later ingest can restate $908,016,796.56 without changing the join definition.

Biology versus treatment: two CFDAs, two joins

Five hundred forty-eight awards totaling $908,016,796.56 sit inside $6,672,662,526.62 on 3,004 awards program-wide. FY2025 is a minority slice by dollars. The implied mean near $1,656,965.00 is a mid-count research texture cue. 548 is not 548 unique labs. This packet does not name institutes, campuses, or investigators. Papers, mechanisms, and survival rates are unpublished. Medical advice is outside this page. Cancer Treatment Research uses CFDA 93.395 and is a different join even when the science sounds related. Do not blend the two year cells.

Cite CFDA 93.396 × FY2025, obligations not outlays. Multi-year project periods can obligate in one year and pay later. CFDA 93.396, FY2025 federal spending, All programs, and All spending ties are the four hrefs. Do not subtract $908,016,796.56 from the program extract and treat the remainder as a published other-year table. Unique recipients stay unpublished. If the program table refreshes, rewrite the dollar sentence and leave the pair labeled Cancer Biology Research crossed with fiscal year 2025.

Biology folklore does not add mechanism lists. $908,016,796.56 on 548 records is CFDA 93.396 in FY2025. Papers, labs, and survival scores stay unpublished. Treatment research is CFDA 93.395. CFDA 93.396, FY2025 federal spending, All programs, and All spending ties are hubs. Medical advice is outside this page. Keep obligations, not outlays.

Questions

How much did Cancer Biology Research obligate in FY2025?

USAspending.gov records $908,016,796.56 across 548 awards for CFDA 93.396 in fiscal year 2025. That is an obligation join, not an outlay, and not a count of labs or papers. The program-wide extract is $6,672,662,526.62 on 3,004 awards. Keep both keys when quoting the year cell.

Is this the same as Cancer Treatment Research?

No. This page is CFDA 93.396 × FY2025 only. Treatment research uses a different assistance code. Program-wide 93.396 facts here are $6,672,662,526.62 and 3,004 awards. Original filings remain on USAspending.gov. Keep both sides of the join when quoting the cell. USAspending.gov remains the source.

Does 548 awards mean 548 laboratories?

No. 548 is the award-record count. Combined with $908,016,796.56, the average is about $1,656,965.00. Unique recipients are unpublished. Renewals add rows. This packet does not name investigators. Keep both sides of the join when quoting the cell. USAspending.gov remains the source.

Where is the live table?

CFDA 93.396 is the program hub. FY2025 federal spending is the year hub. All programs lists other assistance codes. All spending ties lists other joins. Keep both sides when citing $908,016,796.56. Obligations are not outlays. Keep both sides of the join when quoting the cell. USAspending.gov remains the source.